Once a clinician makes the decision to transition/commit a patient to DTE-based thyroid hormone replacement, what do the trials/studies teach us about the comparative treatment, response rates, patient preferences, and outcomes when T4 monotherapy is compared to DTE?
Once a clinician makes the decision to transition/commit a patient to DTE-based thyroid hormone replacement, what do the trials/studies teach us about the comparative treatment, response rates, patient preferences, and outcomes when T4 monotherapy is compared to DTE?
Professor of Medicine, Uniformed Services University of the Health SciencesDirector, Endocrinology Division, Uniformed Services University of the Health Sciences Walter Reed National Military Medical CenterEndocrinology, Diabetes & MetabolismBethesda, MD
